Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
>
Shareholders and investors
> News
News
Find out more about ...
The Share
Investor's Calendar
News
Financial and Business Information
Public Statements Sent to CNMV
ESG
Corporate Governance
News searcher
Year
Year
-Year
2024
2023
2022
2021
2020
2019
2018
Sort by
Fecha publicación
Order
Asc
Desc
ROVI announces the exclusive commercialization of Medikinet y Medicebran in Spain
0 min
27 Nov, 2013
ROVI announces the agreement to market Hirobriz Breezhaler y Ulunar Breezhaler en España
0 min
26 Nov, 2013
Nine-month period ended 30 September 2013 results press release
0 min
07 Nov, 2013
Nine-month period ended 30 September 2013 results presentation
0 min
07 Nov, 2013
2013 first half results press release
0 min
31 Jul, 2013
2013 first half results presentation
0 min
31 Jul, 2013
ROVI exercises the Purchase Option over Rhodogil
0 min
06 Jun, 2013
2013 first quarter results press release
0 min
24 Apr, 2013
2013 first quarter results presentation
0 min
24 Apr, 2013
See more